Takeda Pharmaceutical Company Limited (TYO: 4502)

Takeda Pharmaceutical Company Revenue

Takeda Pharmaceutical Company had revenue of 1.18T JPY in the quarter ending September 30, 2024, with 12.75% growth. This brings the company's revenue in the last twelve months to 4.55T, up 9.43% year-over-year. In the fiscal year ending March 31, 2024, Takeda Pharmaceutical Company had annual revenue of 4.26T with 5.87% growth.

• Revenue (ttm): 4,546.08B
• Revenue Growth: +9.43%
• P/S Ratio: 1.42
• Revenue / Employee: 92.25M
• Employees: 49,281
• Market Cap: 6,507.17B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	4,263.76B	236.28B	5.87%
Mar 31, 2023	4,027.48B	458.47B	12.85%
Mar 31, 2022	3,569.01B	371.19B	11.61%
Mar 31, 2021	3,197.81B	-93.38B	-2.84%
Mar 31, 2020	3,291.19B	1,193.96B	56.93%